Uncomplicated Urinary Tract Infection Market is segmented By Treatment (Antibiotics, Vaccines), By Pathogen Type (Escherichia Coli, Klebsiella Pneumoniae, Proteus Mirabilis), By Therapy (Oral Therapies, IV Therapies), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa). The report offers the value (in USD billion) for the above-mentioned.
The major players operating in the uncomplicated urinary tract infection market include GlaxoSmithKline, Iterum Therapeutics, Fimbrion Therapeutics, Janssen Pharmaceuticals, and Inmunotek.
Uncomplicated Urinary Tract Infection Market